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Abstract
Background: Antiretroviral therapy is effective in preventing the progression of HIV to AIDS, but adherence to HIV
medication is lower than ideal. A previous Cochrane review concluded that SMS interventions increased adherence
to HIV medication, but more recent trials have reported mixed results. Our review aims to provide an up-to-date
synthesis of the effects of interventions delivered by mobile phone on adherence.
Methods: We searched Cochrane, Medline, CINAHL, EMBASE and Global Health for randomised control trials (RCTs)
of interventions delivered by mobile phones, designed to increase adherence to antiretroviral medication. Risk of
bias was assessed using the Cochrane risk of bias tool. We calculated relative risk ratios (RR) or standardised mean
difference (SMD) with 95% confidence interval (CI). Trials were analysed depending on delivery mechanism and
intervention characteristics. We conducted meta-analysis for primary objective outcome measures.
Results: We identified 19 trials. No trials were at low risk of bias. Interventions were delivered as follows; nine via text
message, five via mobile phone call, one via mobile phone imagery and four via mixed interventions. There was no
effect when interventions delivered by text message were pooled in the RR1.25 (CI 0.97 to 1.61) P = 0.08. The SMD 0.42
(0.03 to 0.81) p = 0.04 showed a moderate effect to improve adherence. There was mixed evidence of the effect of text
messages delivered daily, weekly, at scheduled or triggered times, however, messages with link to support, interactivity
and three or more behavior change techniques (BCTs) all improved adherence. Of the five trials delivered by mobile
phone call, one reported a reduction in HIV viral load. One trial using mobile phone imagery reported a reduction in HIV
viral load. Three trials that delivered interventions by text message and mobile phone counselling reported improved
biological outcomes.
Conclusion: Specific interventions, of proven effectiveness should be considered for implementation, rather than
mobile phone-based interventions in general. Interventions targeting a wider range of barriers to adherence may be
more effective than existing interventions. The effects and cost-effectiveness of such interventions should be evaluated
in a randomised controlled trial alongside long term objective and clinically important outcomes.
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Background
There are currently over 36 million people worldwide liv-
ing with HIV [1] with the majority from middle and
low-income countries. Almost 70% of the global HIV dis-
ease burden is in Sub-Saharan Africa [2]. Treatment with
antiretroviral therapy (ART) enables people living with
HIV (PLWH) to lead healthier and longer lives since the
life expectancy of someone who responds to treatment is
the same as the general population [3]. Currently, 59% of
PLWH have access to ART [1].
High adherence to ART is required to suppress viral
replication, to slow the progression of HIV, and further
reduce transmission [4]. Poor adherence can also lead to
drug resistance [5]. UNAIDS aims to ensure 73% of
PLWH achieve viral suppression which is thought to be
2 to 3 times higher than current levels of viral suppres-
sion [6] and the World Health Organisation (WHO) es-
timates that only one-third of the population adhere
appropriately [7].
Factors influencing adherence include individual factors
such as lack of knowledge, misunderstandings about ad-
ministering medicines, lack of skills in developing regular
medicine taking habits (remembering), concerns about side
effects, and social support for medicine taking [8–10].
Medicine related factors, which affect adherence, include
pill burden (number of tablets, intense dosing schedule,
meal time restrictions, medicine side effects) [11–13]. Ser-
vice and structural factors also play a role, such as the
availability of medicine and cost of training health care
providers [14, 15].
Interventions that have demonstrated efficacy in increas-
ing adherence to HIV treatment have had multiple compo-
nents including providing education, counselling, social
support, feedback and additional supervision [11–13].
However, in most settings these have proven too costly or
are unfeasible to deliver in routine service settings.
Mobile phones are a potentially useful, low cost, platform
for delivering health interventions [16]. The World Bank
estimates that 93 in every 100 people are subscribed to mo-
bile phones [17] with low-income countries being the fast-
est growing sector [18]. Interventions delivered by mobile
phones have the potential to target many of the factors in-
fluencing adherence such as knowledge, attitudes, concerns
about medicines and difficulties in developing regular
medicine taking habits [8–10]. They could enhance links to
services so participants can obtain support and advice when
needed, such as if they are experiencing medicine side ef-
fects [19]. Where mobile phones are owned and used by in-
dividuals, privacy can be maintained which is vital for
stigmatised diseases like HIV. Mobile phones are carried
with people wherever they go, so advice and support can be
provided in real time in the patient’s environment [20]. Mo-
bile phones also have the potential to provide support and
training to health care providers, allow remote monitoring
of medicine taking and monitoring of drug supplies with
the potential to reduce drug stock.
A 2011 Cochrane systematic review of trials conducted
between 1980 and 2011, included two trials of interven-
tions delivered by mobile phone and concluded weekly
messaging is effective in increasing adherence to ART [19].
Other systematic reviews that have looked at text message
also support these findings; Finnitis et al. [21], Mayer et al.
[22] and Thakker et al. [23] suggest text messaging im-
proves adherence. Wald et al. [24] looked at the difference
between one-way and two-way message and found the lat-
ter improved adherence.
Our review aims to provide an updated synthesis of
RCTs of interventions designed to increase adherence to
ART medication delivered to patients via mobile phone.
We aim to describe the effectiveness of interventions
which employ different delivery mechanism (SMS, voice
calls, application software) and different intervention con-
tent or frequencies of contact (weekly, daily contact). We
will explore if the effects of interventions vary according to
if they employ interactivity, links to support or use three or
more BCTs.
Methods
This review was conducted in accordance with the
PRISMA guidance. The flowchart can be found in Add-
itional file 1.
Inclusion criteria
Participants – Men and women of any age infected with
HIV who are on or due to start ART. There was no re-
striction of age or stage of treatment.
Intervention – All controlled trials employing any mo-
bile technology to deliver interventions to improve ad-
herence to antiretroviral medication.
Study design – Randomised control trials.
Outcomes – Primary outcomes were objective mea-
sures, which include Medication Event Monitoring Sys-
tem (MEMS), pill count and biological outcomes (CD4
count and viral load). Secondary outcomes were subject-
ive measures (self-reported adherence).
A review protocol does not exist. There were no lan-
guage, geographical or publication status restrictions.
We excluded trials that included more than one disease
and all non-randomised trials including observational
and cross-sectional study designs.
Search strategy
We searched; Cochrane, CINAHL, MEDLINE, EMBASE,
and Global Health databases from 1990 to October 2017.
The EMBASE search strategy of medical subject headings
and text-words can be found in Additional file 2. These
terms were combined with the Cochrane pre-set search
terms for controlled trials. RS searched the reference lists
Shah et al. BMC Public Health          (2019) 19:915 Page 2 of 15
of included papers to identify additional studies for this re-
view. Two reviewers independently scanned the electronic
records to identify potentially eligible trials.
Data extraction
Two reviewers independently extracted data on the
intervention delivery mechanism (e.g. text message,
phone call), intervention characteristics, trial quality and
on measures of effect. Sensitivity analysis was run look-
ing at intervention characteristics, defined as:
(i) Link to support - an intervention that was linked
to a health professional was considered as support,
e.g. the provision of a telephone number.
(ii) Interactivity - when an intervention required the
participant to respond once the intervention has
been received for e.g. sending a text message back
that “everything is okay”. Also referred to as two-
way text message.
(iii)Behaviour change technique - authors description
of interventions according to Abraham and Michie’s
taxonomy of BCTs [25], Additional file 3. An
arbitrary measure of three or more techniques
were used as a cut-off as we estimate that this
number is indicative of interventions which have
considered behaviour change and a wider range
of factors influencing adherence.
All discrepancies were agreed by discussion with a
third reviewer.
Risk of bias was assessed according to the criteria out-
lined by the International Cochrane Collaboration [26]. A
cut off of 90% complete follow-up was used to determine
low risk of bias for attrition.
Data analysis and synthesis
All analyses, including meta-analysis were conducted in
Cochrane Review Manager [27]. All outcomes have been
analysed as intention-to-treat. All loss to follow up has
been treated as non-adherent. We calculated risk ratios
(RR) and standard mean differences (SMD). We used ran-
dom effects meta-analysis appropriately to give pooled esti-
mates of primary outcomes where there were two or more
trials using the same mobile phone delivery mechanism
(e.g. SMS messages) and the same measures of adherence.
We examined heterogeneity visually by examining the for-
est plots and statistically using both the χ2 test and the I2
statistic. We assessed evidence of publication bias using
Funnel plots.
Results
The combined search strategies identified 511 electronic
records. These were screened for eligibility and the full
text of 46 potentially eligible reports were obtained for
further assessment. Nineteen reports met the review in-
clusion criteria and represented 19 trials, the PRISMA
flow diagram can be seen in Additional file 1. Trials that
were excluded from this review can be found in Add-
itional file 7. Three trials were excluded in meta-analysis;
Nsagha [28] and Kebaya [29] only reported subjective out-
comes and Hardy [30] had an intervention as part of the
control group.
Trial characteristics
In total, the 19 trials included 2650 participants. Sample
sizes ranged from 21 to 538 people, the median was 119
participants. Studies took place in South America (Brazil =
1), North America (USA = 4), Asia (India = 1, Pakistan =1,
Malaysia =1, China = 2), Africa (Nigeria =1, Cameroon = 2,
Uganda =1, South Africa = 1, Kenya = 3) and Australasia
(New Zealand =1). All were presented in English. Most tri-
als recruited men and women, however, two groups in-
cluded only women [29, 31].
Interventions – delivery mechanism
Nine interventions were delivered via text message [28,
30–37], five interventions were delivered via mobile phone
call [29, 38–41], one via mobile phone imagery [42], and
four mixed interventions (one automated voice call with
pictorial text [43]), two with counselling and text message
[44, 45] and one with SMS and telephone call reminder
[46]. In all but one trial the control was usual care [30].
The interventions lasted between 6 weeks and 96 weeks.
The maximum number of BCTs employed was 6 [41]
and the median number was 2. The most commonly used
BCTs were: social support (13 interventions), association,
for example prompts/cues (11 interventions) and feedback
& monitoring (8 interventions). More than three BCTs
were used in 5 of the trials [34, 35, 38, 40, 41]. Four trials
specifically reported being based on behaviour change the-
ory [33, 35, 41, 43] and these include social cognitive the-
ory of planned behaviour [43, 47], health belief model
[33], individual change model [35], and behavioural
self-management [41].
Of the 19 mobile phone interventions, five were inter-
active [30, 35, 43–45]. A link to support was provided in
six trials [33, 38, 39, 41, 44, 45].
Details of the interventions, as described by the au-
thors are described in Table 1.
Outcomes
Fifteen different adherence outcome measures were re-
ported. Primary objective outcome measures reported in-
clude six trials recordings MEMs, seven viral measures (5
reported viral load and 2 viral failure) and three trials
measured pill count and CD4 count. The most frequently
reported measure of adherence was the subjective
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secondary outcome, self-reported adherence, in 14 trials.
A complete list is found in Additional file 4.
Trial quality
A risk of bias summary for each trial is presented in
Table 2 with comments in Additional file 5 [48]. No tri-
als had a low risk of bias for all criteria assessed. A fun-
nel plot to show publication bias can be found in
Additional file 6.
Interventions delivered by text message
Nine trials evaluated interventions delivered by text mes-
sage [28, 30–37] which reported a total of 26 outcomes.
An improvement in adherence was measured in seven of
the 19 objective primary outcomes and two of the seven
subjective secondary outcomes. The pooled measures of
text message interventions to improve adherence mea-
sured as MEMs was RR 1.25 (CI 0.97 to 1.61) P = 0.08, ob-
served heterogeneity I2 is 74% [31, 32, 34, 37] and SMD
0.42 (CI 0.03 TO 0.81) P = 0.04, I2 28% [35, 36].
There was substantial variation in all the text message
interventions. The frequency of text messaging was
observed in Pop-eleches trial [32] which compared weekly
and daily messages with the length of the message (long
/short). Of these arms, only weekly text messages showed
a significant result, which was not consistent in the Mbug-
baw trial [33] where weekly text messages were also
delivered. Three trials looked at daily text messages [30,
32, 35] of which two improved adherences [30, 35]. Some
text message interventions were coordinated to their ART
regime (scheduled) [30, 31] and others used real time
monitoring which only sent a text reminder if the partici-
pant failed to open the medication device (triggered) [34,
36, 37]. Haberer [36] specifically looked at this function
and split participants into scheduled and triggered. In this
trial scheduled showed an effect, which was also supported
by Hardy [30]. Triggered interventions showed an effect in
two trials [34, 37]. Some trials only included participants
with poor baseline adherence [30, 34, 35] and all of these
trials reported that the intervention improved adherence.
For biological measures, neither Orrell [37] or Haberer
[36] reported a statistically significant HIV RNA suppres-
sion, however the Orrell trial [37] did report a statistically
significant odds ratio for virological failure which has been
asterisked in Table 3.
Interactivity was identified in 2 trials [30, 35] and both
reported statistically significant improvements in adher-
ence. Three or more BCTs were identified in 3 trials [34–
36], all of which reported an improvement in adherence.
Mbuagbaw [33] and Ingersoll [35] stated a behaviour
change model that underpinned the intervention. Link to
support was reported in one trial [33] which had a statisti-
cally significant effect when the adherence threshold was
reduced from 95 to 90% for Visual Analogue Scale (VAS).
Table 2 Summary risk of bias for each trial
Trial Randomisation Allocation
concealment
Blinding – primary
outcomes
Blinding – secondary
outcomes
Incomplete
outcome
Selective
outcome
reporting
Contamination Other –
general
bias
Abdulrahman 2017 Low Low Low High Low Low Unclear Unclear
Belzer 2014 Low Unclear Low High High Low Unclear High
Da Costa 2012 Low Unclear Low High High Low Unclear Unclear
Haberer 2016 Low Unclear Low Low Low Low Unclear Unclear
Hardy 2011 Low Unclear Low Low High Low Unclear Unclear
Huang 2013 Low Low Low High High Unclear Unclear Unclear
Ingersoll 2015 Low Low Low Low Low Low Unclear Low
Kalichman 2011 Low Unclear Low Unclear Low Low Unclear Unclear
Kebaya 2014 Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear
Lester 2010 Low Low Low High High Low High Unclear
Maduka 2013 Low Low Low High Low Low Low Unclear
Mbuagbaw 2012 Low Low Low High High Low Unclear Unclear
Nsagha 2016 Low Unclear Unclear High Unclear Low Unclear Unclear
Orrell 2015 Low Low Low Low Low High Unclear Unclear
Perera 2014 Unclear Unclear Low High Low Unclear Unclear Unclear
Pop-Eleches 2011 Low Unclear Low Low Low Unclear Unclear Unclear
Sabin 2015 Low Low Low Low Low Low Unclear Unclear
Shet 2014 Low Low Low Low Low Low Low Unclear
Uzma 2011 Low Unclear Low High High High Unclear Unclear
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Figures 1 and 2 Forest plot of primary outcome adher-
ence (measured as MEMs) in interventions delivered by
text message. Relative risk and SMD.
Interventions delivered by mobile phone call
Five trials evaluated interventions delivered by mobile
phone call which reported a total of 12 outcomes [29, 38–
41]. An improvement in adherence was measured in one of
the 6 objective primary outcomes and in three of the 6 sec-
ondary subjective outcomes reported. One trial [38] showed
a reduction in HIV viral load. The Huang [39] trial split the
group into treatment naïve and treatment experienced.
Two trials looked at participants that were not adherent
[38, 41], only Belzer [38] improved adherence. No trials
were similar enough to pool (Table 4).
Link to support was identified in 3 trials [38, 39, 41] and
three or more BCTs were found in 3 trials [38, 40, 41]. Of
these only Belzer [38] showed an improvement in adher-
ence. Only Kalichman [41] explicitly stated a behaviour
change model that underpinned the intervention. Mobile
phone calls by nature were interactive.
Interventions delivered by mobile phone imagery
One trial [42] reported four objective outcome results of
interventions delivered by mobile phone imagery. One
outcome showed a statistically significant improvement
in HIV viral load (Table 5).
Interventions delivered by mixed intervention
Four trials evaluated interventions delivered by mixed
mechanism [43–46] and reported a total of 10 outcomes.
Table 3 summary tables of primary and secondary outcomes of interventions delivered by text message
Frequency of Interventions
delivered by text message.
Trial outcome RR SMD LCI UCI P value
Primary outcome
All text Pop-eleches Medication Events Monitoring 1.17 0.92 1.48 0.20
Weekly text Pop-eleches Medication Events Monitoring 1.32 1.02 1.70 0.03
Short text Pop-eleches Medication Events Monitoring 1.16 0.89 1.52 0.27
Long text Pop-eleches Medication Events Monitoring 1.17 0.90 1.53 0.24
Daily text Pop-eleches Medication Events Monitoring 1.01 0.76 1.35 0.92
Weekly text Mbuagbaw Pharmacy refill data 0.1 −0.23 0.43 0.62
Scheduled/5x week Da Costa Pill count 1.35 0.61 3.00 0.46
Scheduled/5x week Da Costa Mediation Events Monitoring 1.39 0.73 2.65 0.31
Daily text Hardy Medication Events Monitoring System 33.4 14.1 52.6 0.00
Scheduled/ Daily Hardy Pill count 13.7 −6.7 34.1 0.15
Scheduled/ Daily Hardy Composite adherence score 27.1 7.6 46.6 0.01
Triggered Sabin Medication events Monitoring 1.69 1.28 2.20 0.00
Scheduled Haberer Medication Events Monitoring 12.00 1.83 22.17 0.03
Triggered Haberer Medication Events Monitoring 0.00 −12.28 12.28 1.00
Haberer HIV RNA Suppression 0.14
Daily Ingersoll Pharmacy refill data 12.20 1.11 23.29 0.04
Triggered Orrell Medication Events Monitoring 1.02 0.90 1.15 0.73
Triggered Orrell Suppressed HIV RNA < 40 copies 1.05 0.93 1.18 0.46
Triggered Orrell Virological failure *OR 2.03 1.1 3.9 0.034
Secondary outcome
Weekly text Mbuagbaw Self-reported adherence 1.01 0.87 1.16 0.94
Weekly text Mbuagbaw Visual Analogue Scale > 95% 1.07 0.89 1.29 0.48
Weekly text Mbuagbaw Visual Analogue Scale > 90% 1.14 1.01 1.30 0.03
5 times a week Da Costa Self-reported adherence 1.06 0.83 1.35 0.65
Daily text message Hardy Self-reported adherence 20.2 −1.8 42.1 0.07
4 times a week Nsagha Self-reported adherence 1.53 1.02 2.29 0.04
Triggered Orrell Self report/ tablet return 1.00 1.00
Clinically significant results (P < 0.05) have been highlighted in bold
* refers to odds ratio
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There were six primary outcomes and four secondary out-
comes. All of the outcomes except for the Shet trial [43]
reported improvements in adherence. The Adbulrahman
trial [46] reported a difference in mean adherence in the
intervention group as statistically significant (p = 0.035).
They also reported significant biological differences be-
tween the control and intervention group - a significantly
higher rise in CD4 count (p = 0.017) in the intervention
group and higher viral load in the control group (p =
0.001). In both Abdulrahman [46] and Maduka’s trial [45]
we were unable to calculate RR or MD based on the data
provided. Maduka’s report a statistically significant (95%
CI P = 0.007) improvement in median CD4 count [45].
The Lester trial [44] which also involved text messaging
and telephone follow up (for those requesting it or not
responding) showed a statistically significant improvement
in adherence (Table 6).
Interactivity was identified in three trials [43–45] of
which two showed an effect. Link to support was identi-
fied in two trials [44, 45] all showed statistically signifi-
cant improvements in adherence. Maduka [45] reported
improvements in adherence in both objective and sub-
jective measures (CD4 improvement and SRA). None of
the mixed interventions used behaviour change models
or reported having more than three or more BCTs as
part of their interventions.
Discussion
We identified 19 trials that investigated the effect of dif-
ferent mobile phone mechanisms on adherence to HIV
medication. This review used a systematic approach, a
replicable search strategy and standard systematic review
methods [48] and is the first to include interventions de-
livered by mobile phone call. Previous reviews of mobile
phone interventions designed to increase ART adherence
have grouped all “mobile phone interventions that used
any text messages” together without differentiating be-
tween interventions delivered via text message and mo-
bile phone call, and BCTs used in the interventions were
not described.
We present pooled analyses of objective outcomes and
our review is the first to differentiate between objective
and subjective adherence measures. Self-reported adher-
ence outcomes may differentially overestimate benefits
in the intervention group [49] due to lack of participant
blinding, recall bias and the desire to please the provider
[7]. We only pooled objective measures of the same out-
come as such analyses allow the clinical benefits
achieved for patients to be more clearly interpreted.
We found no effect when interventions delivered by
text message were pooled in the RR, however, there was
a moderate effect in SMD. There was substantial hetero-
geneity across the trials and individual trials reported
objective improvements in adherence. It was unclear if
the delivery mechanism (daily, weekly, scheduled or trig-
gered mechanism in text messages) had an effect since,
individually, the results were of mixed statistical signifi-
cance. Text message interventions described as ‘inter-
active’ and using more than three BCTs all showed
improvements in adherence. None of the trials had a
low risk of bias.
Previous reviews have found that text messaging is ef-
fective in increasing adherence to ART [19, 22, 23],
Finitsis et al. [21], reported a pooled OR of 1.48 (1.09 to
Fig. 1 Adherence to HIV medication measured as MEM with interventions delivered by text message RR
Fig. 2 Adherence to HIV medication measured as MEM with interventions delivered by text message SMD
Shah et al. BMC Public Health          (2019) 19:915 Page 10 of 15
2.01) on any HIV outcome, however, objective and sub-
jective outcomes were pooled across all types of inter-
vention provided they included some text messaging.
Although pooling in this way affords greater statistical
power, use of subjective outcomes in trials where partici-
pants cannot be blinded may have resulted in
over-estimated effects and it is difficult to identify which
intervention components were effective. A similar meth-
odology was used in Thakkar et al. [23] which concluded
that mobile phone text message approximately doubles
medication adherence in chronic disease. This review in-
cluded trials [44, 45] combining text message with coun-
selling, which may have inflated results [23]. Mayer et al.
[22] also reported a larger SMD than the SMD we calcu-
late in our review (SMD 0.87 vs. SMD 0.42), however,
the authors included trials with a pre-post study design,
converted all outcomes to SMD, and pooled all trials
that included any text message.
We find the effect of text message-delivered daily
prompts to take medicines to be inconclusive. This is
consistent with the findings of other trials of text
message-delivered daily prompts designed to increase
adherence to oral contraception, TB medication, malaria
prophylaxis or antibiotics, pooled RR 1.0 (CI 0.77–1.3)
[31, 33, 50]. Intervention fatigue may explain the inef-
fectiveness of daily medication prompts.
All text message interventions with interactivity in-
cluded in this review improved adherence, however we
were unable to pool results (differing outcome measures
and Hardy et al. [30] used an intervention as the con-
trol). This finding supports the conclusions of the Wald
et al. [24] systematic review which explored the effects
of two-way communication and interactivity in mobile
phone-delivered interventions targeting adherence to
any medication and concluded that interventions involv-
ing two-way text messaging improved medication adher-
ence [24]. Mbuagbaw et al. also showed that interactivity
improved adherence to ART [51] and Finnitis reports
that interventions which include interactivity are more
effective [21].
In our review, we distinguish between interactivity and
a specific link to support from a person. These charac-
teristics were heterogeneous, which is unsurprising given
the nature of interactivity varied e.g. texting back to con-
firm you have taken medicine rather than texting back if
you would like to speak to a health care provider, and
the nature of the link to support could require passive
or active involvement (a phone call from a health care
Table 5 Summary of primary outcome of mobile phone interventions delivered by images
Intervention Trial Primary outcome - continuous data RR SMD LCI UCI P value
Daily imagery Perera Medication adherence 1.84 −0.40 4.08 0.06
Daily imagery Perera Prescribed doses taken 1.56 −1.99 5.12 0.32
Daily imagery Perera Pharmacy dispensing 6.80 . . .
Daily imagery Perera HIV viral load log 10 −0.40 −0.78 −0.02 0.02
Clinically significant results (P < 0.05) have been highlighted in bold
Table 4 Summary of primary and secondary outcome of mobile phone interventions delivered by phone call
Frequency of Interventions delivered
by phone call
Trial Outcome RR SMD LCI UCI P value
Primary outcome
Weekly phone call Uzma HIV viral load 1.04 0.84 1.28 0.74
Weekly phone call Uzma Pill identification test 1.17 0.88 1.57 0.28
Daily phone-call Belzer HIV viral load difference −1.00 −1.89 −0.11 0.03
Bi-weekly phone counseling Kalichman Pill count 6.30 −2.68 15.28 0.16
Fortnightly phone call Huang naïve CD4 count 10.00 −40.90 60.90 0.70
Fortnightly phone call Huang experienced CD4 count −32.00 −103.19 39.19 0.39
Secondary outcome
Fortnightly phone call Kebaya Adherence 6 weeks (questionnaire) 1.26 1.07 1.47 0.00
Weekly phone call Uzma Self reported adherence 1.11 0.90 1.37 0.33
Daily phone call Belzer Self-reported adherence 3 months 4.86 1.22 19.28 0.03
Daily phone-call Belzer Self-reported adherence 47.74 19.52 75.96 0.00
Fortnightly phone call Huang naïve Self-reported adherence 3.20 −2.14 8.54 0.22
Fortnightly phone call Huang experienced Self-reported adherence 0.10 −0.58 0.78 0.78
Clinically significant results (P < 0.05) have been highlighted in bold
Shah et al. BMC Public Health          (2019) 19:915 Page 11 of 15
provider because you requested one or because you
didn’t respond or a telephone number to call if further
advice was needed). Trials of interventions that involve
sending a text message and providing phone follow up
from a health care provider report increased uptake of
long acting contraception and increase adherence to pre-
ventative medication for cardiovascular disease, as well
as increase adherence to antiretroviral medication and
reduce viral load [52, 53].
Among the five trials of interventions delivered by mo-
bile phone call included in this review, only one reported
a statistically significant reduction in viral load post
intervention [32]. One trial using mobile phone imagery
reported a reduction in HIV viral load. It is likely that
the effect of interventions delivered by mobile phone
call would be similar to the effect of adherence inter-
ventions delivered by landline - SMD in pooled be-
havioural outcomes 0.49 (− 1.12 to 2.11) I240%, [54].
The content of calls in both our review and the
Cochrane review of phone calls was generally poorly
described and is likely to be variable, resulting in dif-
ferent effects across trials [54]. In the one trial in our
review which reported beneficial effects, the interven-
tion was well described and involved confirming if
medications were taken, providing problem-solving
support, and referral to services to address adherence
barriers if needed [38].
Of the mixed trials in our review, one trial delivered by
mobile automated phone voice messaging showed no bene-
fit, however, the other three mixed trials reported benefit,
either in increasing CD4 count or reducing viral load [44–
46]. All of the mixed interventions which included a link to
support improved adherence, however, the time and costs
involved requires clarification.
A wide range of other factors influence adherence to
ART but have not been targeted in interventions to date.
These factors include information about how medicines
work, why they are important and how to take them,
how to develop regular medicine taking habits, reassur-
ance regarding common minor side effects and informa-
tion about side effects for which help should be sought.
The interventions in this review contained few BCTs
(median 2 and maximum 6). In other areas such as
smoking cessation effective behaviour change interven-
tions delivered by text message included 19 BCTs [55].
Our review has some important limitations. With no
existing gold standard objective measures of adherence
[56, 57], trials included in this review used 15 different ad-
herence measures limiting our ability to conduct pooled
analyses of the same outcomes. There were also too few
trials to conduct a meta-regression exploring all the fac-
tors which could influence heterogeneity of outcomes in-
cluding: allocation concealment, blinding of outcome
assessors, types of participant (treatment experienced/
naive), factors influencing adherence targeted, BCT
employed, mode of delivery, and duration of follow up.
Adherence measures may be at risk of the ‘Hawthorne
effect’, where participants alter their behaviour due to
awareness of being observed, especially if there is con-
siderable contact in mid-trial follow-up points [58].
Self-reported measures and measures that can be manip-
ulated in the short term such as pill count will be more
susceptible to this effect.
It is also important to consider that in RCT’s the con-
trol group may have higher adherence levels by virtue of
trial participation and increased surveillance, which may
reduce the ability to detect true differences in the trial
and thus underestimate intervention effects. In
Table 6 Summary of primary and secondary outcome of mobile phone interventions delivered by mixed method
MIXED Trial Outcome RR SMD LCI UCI P value
Primary
Twice a week text message + monthly adherence counselling Maduka CD4 count change . . . . .
Weekly voice message and pictoral Shet Virological failure 1.00 0.70 1.44 0.99
Weekly voice message and pictoral Shet Suboptimal adherence to
ART (pill count)
1.24 0.93 1.65 0.14
Weekly text + counselling Lester Viral suppression 1.18 1.01 1.40 0.04
SMS and telephone call reminder Abdulrahman Viral load . . . . .
SMS and telephone call reminder Abdulrahman CD4 . . . . .
Secondary
Twice a week text message + monthly adherence counselling Maduka Self–reported adherence 1.38 1.04 1.83 0.03
Weekly text + counselling Lester ITT self-reported
adherence > 95%
1.24 1.06 1.44 0.01
SMS and telephone call reminder Abdulrahman Self-reported adherence - good 1.81 1.49 2.20 0.00
SMS and telephone call reminder Abdulrahman Average adherence 8.21 6.42 10.00 0.00
Clinically significant results (P < 0.05) have been highlighted in bold
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pragmatic trials there may be a trade-off between main-
taining internal validity by achieving high follow up and
achieving generalisability for “real world” purposes.
We coded the BCTs using an established taxonomy [25],
however, coding was dependant on the authors’ descrip-
tion of the intervention, which often lacked detail. More
comprehensive descriptions were requested but responses
were limited, especially for transcripts of mobile phone call
interventions. It is likely that content of mobile phone calls
differed between trials which may influence the outcome
of mobile phone counselling interventions.
Many of the trials had small sample sizes and were
therefore underpowered to detect changes in the out-
comes collected. As mentioned before, we did not pool
analyses across different outcomes also resulting in re-
duced statistical power. The median follow-up time across
trials was 4 months which is insufficient to determine the
long-term impact of the intervention - some studies sug-
gest that adherence slowly decreases with time due to pill
fatigue [59].
WHOs current advice is there is high quality evidence for
weekly text messages and they are effective to enhance ad-
herence [60] . The evidence is more nuanced than this advice
suggests, and new recommendations based on the updated
evidence can now be made which recommend only specific
interventions that have been shown to be effective.
Cost-analyses of existing effective interventions is
needed prior to considering widespread implementation.
Further clarification regarding the aims or content of
phone calls would be helpful for services considering im-
plementation. Future trials should include an exploration
of the mechanism of action of interventions. The evidence
base would be enhanced if a gold standard measure of
ART adherence were agreed internationally. Interventions
targeting a wider range of factors influencing adherence
might have greater effects than existing interventions and
should be evaluated by randomised controlled trial.
Conclusions
Our review demonstrates text message improves adherence
when measured as SMD but not RR. Interventions deliv-
ered by text message combined with health care provider
mobile phone call have benefits on clinically important out-
comes and text message interventions that include a link to
a health care professional, interactivity and three or more
BCTs all showed improvements in objective adherence
measures. The evidence supports consideration of specific
interventions shown to be effective for implementation, ra-
ther than mobile phone-based interventions in general. In-
terventions targeting a wider range of barriers to adherence
and exploring other mechanisms may be more effective
than existing interventions and may reduce the amount of
health care provider input needed. Such interventions
should be evaluated in a randomised controlled trial with
long-term objective and clinically important outcomes
alongside associated cost-effective analysis.
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